Related Experiment Video
Updated: Aug 16, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
DNA content as a prognostic factor in endometrial carcinoma
R Newbury1, C Schuerch, N Goodspeed
1Department of Laboratory Medicine, Geisinger Medical Center, Danville, Pennsylvania.
Aneuploidy in endometrial cancer, detected by DNA analysis, strongly predicts disease-related death, especially in high-grade or papillary serous types. This DNA content may guide adjuvant therapy decisions for specific patient subgroups.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Endometrial carcinoma is a common gynecologic malignancy.
- Accurate prognostic markers are crucial for treatment stratification.
- DNA content analysis offers potential insights into tumor behavior.
Purpose of the Study:
- To investigate the prognostic value of DNA content analysis in endometrial carcinoma.
- To correlate DNA ploidy status with clinicopathologic features and patient outcomes.
- To identify potential applications of DNA analysis in treatment selection.
Main Methods:
- Flow cytometry was used to analyze DNA content in cell nuclei from 233 archival endometrial carcinoma paraffin blocks.
- Median follow-up was 8.7 years.
- Correlation of DNA index and cell cycle phases with histologic type, grade, invasion depth, stage, and patient survival was performed.
Main Results:
- Aneuploidy was found in 18% of tumors and associated with adverse histologic type, high grade, and deep myometrial invasion.
- Aneuploidy was absent in low-grade carcinomas.
- A DNA index > 1.5 was a strong predictor of death from disease, independent of stage or grade in adenocarcinomas and papillary serous carcinomas.
- S phase or G2+M phase percentages did not predict outcome in diploid tumors.
Conclusions:
- DNA content analysis, particularly aneuploidy and a DNA index > 1.5, serves as a significant prognostic marker in endometrial carcinoma.
- DNA analysis may aid in selecting patients with low-stage, high-grade, or papillary serous endometrial cancers for adjuvant therapy.
- Further application of DNA content analysis could refine risk stratification and personalize treatment strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle

